BCRX - BioCryst Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue20,65325,18626,35348,257
Cost of Revenue85,35968,66463,70774,654
Gross Profit-64,706-43,478-37,354-26,397
Operating Expenses
Research Development----
Selling General and Administrative18,51413,93311,25313,047
Non Recurring----
Others----
Total Operating Expenses103,87382,59774,96087,701
Operating Income or Loss-83,220-57,411-48,607-39,444
Income from Continuing Operations
Total Other Income/Expenses Net-18,032-8,371-6,537-3,575
Earnings Before Interest and Taxes-83,220-57,411-48,607-39,444
Interest Expense-9,176-8,565-6,487-5,200
Income Before Tax-101,252-65,782-55,144-43,019
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-101,252-65,782-55,144-43,019
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-101,252-65,782-55,144-43,019
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-101,252-65,782-55,144-43,019